The Valley Desk

NCT03987295 · Interventional trial

A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)

Overall registry status Completed

Phase 2

Conditions Frontotemporal Dementia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov